Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domperidone for prevention of pneumonia in hospitalized stroke patients
IRCT20201001048896N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of domperidone in pneumonia (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Need for intubation, Duration of hospitalization and 2 more. Started Jan 2021; status: completed.
02
Drugs
domperidone
03
Conditions
pneumonia
Beyond the preview
Go deeper on IRCT20201001048896N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201001048896N1.